✦ LIBER ✦

Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours

✍ Scribed by A. LÓPEZ-POUSA; J. RIFÀ; A. CASAS DE TEJERINA; J.L. GONZÁLEZ-LARRIBA; C. IGLESIAS; J.A. GASQUET; A. CARRATO

Book ID: 108710801
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 204 KB
Volume: 19
Category: Article
ISSN: 0961-5423
DOI: 10.1111/j.1365-2354.2009.01121.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and validation of a predicti

Development and validation of a prediction model for the risk of developing febrile neutropenia in the first cycle of chemotherapy among elderly patients with breast, lung, colorectal, and prostate cancer

✍ Wylie Hosmer; Jennifer Malin; Mitchell Wong 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 149 KB

Increased risk of myelotoxicity in elder

Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma : The case for routine prophylaxis with colony-stimulating factor beginning in the first cycle of chemotherapy

✍ Lodovico Balducci; Lazzaro Repetto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Neutropenia is the major dose‐limiting toxicity of myelosuppressive chemotherapy in patients with cancer. Because of the high incidence of neutropenic complications and death in the early cycles of chemotherapy and the potential for improved outcomes, prophylaxis with colony‐stimulating factor begin